| Cohort_1 (n = 21) | Cohort_2 (n = 23) | Cohort_3 (n = 73) |
---|---|---|---|
Gender | |||
 Male (%) | 61.9 | 30.4 | 53.4 |
 Female(%) | 38.1 | 69.6 | 46.6 |
Age (Range) | 67 (52–79) | 67 (47–84) | 65 (40–82) |
Stage | |||
 I-II (%) | / | / | 28.7 |
 III (%) | 57.1 | 56.5 | 39.7 |
 IV(%) | 42.9 | 43.5 | 31.6 |
Tumor site | |||
 Head | 43.3 | 26.1 | 64.7 |
 Body | 29.0 | 47.8 | 19.1 |
 Tail | 19.0 | 17.4 | 6.8 |
 Multi localized | 8.7 | 8.7 | 9.4 |